SCHEMBL6833965

SCHEMBL6833965

O=C(O)c1cc(Br)ccc1NC(=O)c1onc2ccc(S(=O)(=O)N3CCCC3)cc12

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALB P02768 3/20 0.54
PPARG P37231 1/20 0.47
PPARD Q03181 1/20 0.47
PPARA Q07869 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
HSD17B10 Q99714 2/20 0.47
TP53 P04637 3/20 0.47
MAPT P10636 3/20 0.47
RXFP1 Q9HBX9 1/20 0.47
LMNA P02545 2/20 0.44
GAA P10253 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 3/20 0.42
POLB P06746 2/20 0.42
TSHR P16473 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833780 0.86 ALB (0.55) ALBPPARGPPARDPPARAMEN1
SCHEMBL6818370 0.85 METAP2 (0.44) ALBPPARGPPARDPPARAMEN1
SCHEMBL6818553 0.83 AKR1C2 (0.50) ALBMEN1KMT2AMAPTTDP1
SCHEMBL6819170 0.82 MEN1 (0.44) ALBMEN1KMT2AMAPTRXFP1
SCHEMBL6818686 0.80 ALB (0.69) ALBHSD17B10MAPTRXFP1LMNA
SCHEMBL6833802 0.79 ALB (0.66) ALBPPARGPPARDPPARAMEN1
SCHEMBL6356877 0.79 ALB (0.65) ALBPPARGPPARDPPARAMEN1
SCHEMBL6818060 0.77 AKR1C2 (0.51) MEN1KMT2AMAPTTDP1ALDH1A1
SCHEMBL6357153 0.77 ALB (0.83) ALBPPARGPPARDPPARAMEN1
SCHEMBL6834683 0.74 ALB (0.59) ALBMEN1KMT2AHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 ALB 1417/4885PPARG 285/4885PPARD 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.